Stories explained

The 2022 long-COVID xenon MRI study: what the early lung findings showed

A small study detected impaired gas transfer in some people with persistent breathlessness despite routine CT findings. It did not prove permanent lung damage in everyone with long COVID.

Historical research explanation, not a diagnosis or treatment recommendation. Persistent or worsening symptoms should be discussed with a qualified clinician.

What the researchers measured

Oxford's January 31, 2022 account of the EXPLAIN research described hyperpolarized xenon MRI scans in a small group of people with persistent breathlessness after COVID-19 who had not been hospitalized. The method tracked movement of inhaled xenon from the lungs into the bloodstream, revealing abnormalities not apparent on their routine CT scans.

A scan measuring gas transfer asks a different question from an image primarily showing lung structure. Different tests can therefore reveal different aspects of physiology without one result automatically invalidating another.

Source [1]

The limits are part of the finding

Oxford explicitly described the results as initial and said a larger study was underway. The early group cannot establish how common the finding is across everyone with long COVID, how long every abnormality persists or which treatment will help a particular patient.

The useful conclusion is narrower: a specialized research method identified a possible physiological explanation worth investigating in some patients with breathlessness. It does not justify diagnosing yourself from a headline, assuming irreversible damage or dismissing symptoms because a standard scan was normal. The linked Health section separates current reporting from this dated study account.

Source [1]

Sources and further reading

  1. University of Oxford DPAG — Hidden lung damage study, January 31, 2022 ↗